Searched over 200M research papers for "patho diabetes"
10 papers analyzed
These studies suggest that type 2 diabetes is influenced by defective insulin secretion, insulin resistance, genetic factors affecting beta-cell function, early life health, and metabolic interorgan crosstalk, with individualized treatment and multiple antidiabetic agents being crucial for effective management.
19 papers analyzed
Diabetes mellitus is a complex metabolic disorder characterized by chronic hyperglycemia due to defects in insulin secretion, insulin action, or both. The two primary types of diabetes, Type 1 and Type 2, have distinct pathophysiological mechanisms but share common complications and health risks.
Type 1 diabetes (T1D) is primarily caused by an autoimmune response that leads to the destruction of insulin-producing beta cells in the pancreas. Genetic predisposition and environmental factors, such as viral infections, play significant roles in the onset of T1D.
Type 2 diabetes (T2D) is a multifactorial disease resulting from a combination of insulin resistance and beta-cell dysfunction. Genetic factors contribute significantly to T2D, with numerous risk genes identified through genome-wide association studies. Environmental factors, including obesity, unhealthy diet, and physical inactivity, exacerbate the condition by promoting insulin resistance and metabolic stress.
In T2D, defective insulin secretion by pancreatic beta cells and the inability of insulin-sensitive tissues to respond appropriately to insulin are central to the disease's pathophysiology. Molecular mechanisms involved in insulin synthesis, release, and detection are tightly regulated, and defects in these processes lead to metabolic imbalances.
Recent studies have highlighted the role of forkhead box protein O (FOXO) transcription factors in diabetes. FOXO proteins integrate various biological functions to promote metabolic flexibility, controlling glucose and lipid metabolism in the liver and maintaining beta-cell differentiation. Loss of FOXO function is associated with beta-cell dedifferentiation, a key factor in diabetes progression.
Research has identified distinct subphenotypes of T2D based on variables such as glycemia, body fat distribution, liver fat content, and genetic risk. These subphenotypes have different risks for developing diabetes and its complications, highlighting the need for personalized treatment approaches.
Interorgan crosstalk, involving signaling between tissues through secreted factors like hormones and metabolites, plays a crucial role in T2D. Dysregulated blood glucose and long-lasting hyperglycemia are associated with changes in metabolism, affecting physiological homeostasis and contributing to disease development.
Individuals with T2D are at high risk for both microvascular complications (retinopathy, nephropathy, neuropathy) and macrovascular complications (cardiovascular diseases). Hyperglycemia and components of the insulin resistance syndrome are key contributors to these complications.
The progression from prediabetes to overt diabetes is marked by a decline in beta-cell function and worsening insulin resistance. Factors such as higher BMI, blood pressure, and triglycerides, along with lower HDL cholesterol, predict the development of diabetes.
Understanding the pathophysiology of diabetes is crucial for developing effective prevention and treatment strategies. Advances in genetic research, molecular biology, and the identification of distinct subphenotypes provide valuable insights into the disease mechanisms. Personalized medical approaches, considering the heterogeneity of diabetes, hold promise for better management and improved patient outcomes.
Most relevant research papers on this topic